The Danish randomized trial of trifluridine–tipiracil and bevacizumab in metastatic colorectal cancer: final survival and post hoc neutropenia and quality-of-life analyses
The Danish randomized trial of trifluridine–tipiracil and bevacizumab in metastatic colorectal cancer: final survival and post hoc neutropenia and quality-of-life analyses. // ESMO Gastrointestinal Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2949819826000701?dgcid=rss_sd_all
The Danish randomized trial of trifluridine–tipiracil and bevacizumab in metastatic colorectal cancer: final survival and post hoc neutropenia and quality-of-life analyses. ESMO Gastrointestinal Oncology. https://www.sciencedirect.com/science/article/pii/S2949819826000701?dgcid=rss_sd_all
“The Danish randomized trial of trifluridine–tipiracil and bevacizumab in metastatic colorectal cancer: final survival and post hoc neutropenia and quality-of-life analyses.” ESMO Gastrointestinal Oncology.
@article{article44855,
title = {The Danish randomized trial of trifluridine–tipiracil and bevacizumab in metastatic colorectal cancer: final survival and post hoc neutropenia and quality-of-life analyses},
journal = {ESMO Gastrointestinal Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2949819826000701?dgcid=rss_sd_all}
}